Ichinoe M - Search Results

1

REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response.

Tamaki A, Kato T, Sakurai Y, Sato K, Adachi K, Tadehara M, Kogami T, Matsushita M, Hoshino A, Sanoyama I, Numata Y, Umezawa A, Ichinoe M, Ichihara M, Kusano C, Murakumo Y. Tamaki A, et al. Among authors: ichinoe m. Cancer Sci. 2024 Feb;115(2):660-671. doi: 10.1111/cas.16044. Epub 2023 Dec 21. Cancer Sci. 2024. PMID: 38130032 Free PMC article.

2

Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression.

Mikami T, Nemoto Y, Numata Y, Hana K, Nakada N, Ichinoe M, Murakumo Y, Okayasu I. Mikami T, et al. Among authors: ichinoe m. Hum Pathol. 2013 Dec;44(12):2628-35. doi: 10.1016/j.humpath.2013.07.020. Epub 2013 Oct 10. Hum Pathol. 2013. PMID: 24119563

3

High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas.

Yanagisawa N, Hana K, Nakada N, Ichinoe M, Koizumi W, Endou H, Okayasu I, Murakumo Y. Yanagisawa N, et al. Among authors: ichinoe m. Cancer Med. 2014 Oct;3(5):1246-55. doi: 10.1002/cam4.272. Epub 2014 Jun 2. Cancer Med. 2014. PMID: 24890221 Free PMC article.

4

L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.

Yanagisawa N, Satoh T, Hana K, Ichinoe M, Nakada N, Endou H, Okayasu I, Murakumo Y. Yanagisawa N, et al. Among authors: ichinoe m. Cancer Biomark. 2015;15(4):365-74. doi: 10.3233/CBM-150486. Cancer Biomark. 2015. PMID: 25835180

5

L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.

Ichinoe M, Yanagisawa N, Mikami T, Hana K, Nakada N, Endou H, Okayasu I, Murakumo Y. Ichinoe M, et al. Pathol Res Pract. 2015 Jul;211(7):533-8. doi: 10.1016/j.prp.2015.03.007. Epub 2015 Apr 7. Pathol Res Pract. 2015. PMID: 25908107

6

CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

Yokoyama M, Ichinoe M, Okina S, Sakurai Y, Nakada N, Yanagisawa N, Jiang SX, Numata Y, Umezawa A, Miyazaki K, Higashihara M, Murakumo Y. Yokoyama M, et al. Among authors: ichinoe m. Int J Hematol. 2017 May;105(5):614-622. doi: 10.1007/s12185-016-2173-1. Epub 2016 Dec 28. Int J Hematol. 2017. PMID: 28032275

7

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.

Igawa S, Sato Y, Ryuge S, Ichinoe M, Katono K, Hiyoshi Y, Otani S, Nagashio R, Nakashima H, Katagiri M, Sasaki J, Murakumo Y, Satoh Y, Masuda N. Igawa S, et al. Among authors: ichinoe m. Oncology. 2017;92(5):283-290. doi: 10.1159/000458412. Epub 2017 Feb 22. Oncology. 2017. PMID: 28222447

8

Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.

Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N. Ryuge S, et al. Among authors: ichinoe m. PLoS One. 2017 Mar 30;12(3):e0173886. doi: 10.1371/journal.pone.0173886. eCollection 2017. PLoS One. 2017. PMID: 28358810 Free PMC article.

9

Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.

Katono K, Sato Y, Kobayashi M, Saito K, Nagashio R, Ryuge S, Igawa S, Nakashima H, Shiomi K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Masuda N. Katono K, et al. Among authors: ichinoe m. Oncol Res Treat. 2017;40(10):594-602. doi: 10.1159/000478100. Epub 2017 Sep 19. Oncol Res Treat. 2017. PMID: 28950283

10

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma.

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N. Katono K, et al. Among authors: ichinoe m. Onco Targets Ther. 2017 Nov 2;10:5273-5279. doi: 10.2147/OTT.S145072. eCollection 2017. Onco Targets Ther. 2017. PMID: 29138580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page